These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6279250)

  • 1. Changes in hippocampal CA1 population spikes following administration of delta-9-THC.
    Weisz DJ; Gunnell DL; Teyler TJ; Vardaris RM
    Brain Res Bull; 1982 Feb; 8(2):155-62. PubMed ID: 6279250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. delta9-tetrahydrocannabinol and the hippocampus: effects on CA1 field potentials in rats.
    Vardaris RM; Weisz DJ
    Brain Res Bull; 1977; 2(3):181-7. PubMed ID: 890504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The actions of THC on the intact hippocampus: a comparison of dentate and CA1 responses.
    Wilkison DM; Pontzer NJ
    Brain Res Bull; 1987 Jul; 19(1):63-7. PubMed ID: 2820552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal CA1 lacunosum-moleculare interneurons: modulation of monosynaptic GABAergic IPSCs by presynaptic GABAB receptors.
    Khazipov R; Congar P; Ben-Ari Y
    J Neurophysiol; 1995 Nov; 74(5):2126-37. PubMed ID: 8592201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta 9-tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture.
    Kelley BG; Thayer SA
    Neuropharmacology; 2004 Apr; 46(5):709-15. PubMed ID: 14996548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of hippocampal acetylcholine turnover in rats treated with (-)-delta 8-tetrahydrocannabinol and its 1',2'-dimethyl-heptyl homolog.
    Revuelta AV; Cheney DL; Costa E; Lander N; Mechoulam R
    Brain Res; 1980 Aug; 195(2):445-52. PubMed ID: 6249445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. delta 9-Tetrahydrocannabinol and cannabidiol: dose-dependent effects on evoked potentials in the hippocampal slice.
    Kujtan PW; Carlen PL; Kapur BM
    Can J Physiol Pharmacol; 1983 Apr; 61(4):420-6. PubMed ID: 6305469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic actions of general anesthetics are responsible for frequency-dependent modification of synaptic transmission in the rat hippocampal CA1.
    Hirota K; Sasaki R; Roth SH; Yamazaki M
    Anesth Analg; 2010 Jun; 110(6):1607-13. PubMed ID: 20435940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA(B) receptors inhibit backpropagating dendritic spikes in hippocampal CA1 pyramidal cells in vivo.
    Leung LS; Peloquin P
    Hippocampus; 2006; 16(4):388-407. PubMed ID: 16411229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro.
    Nowicky AV; Teyler TJ; Vardaris RM
    Brain Res Bull; 1987 Dec; 19(6):663-72. PubMed ID: 2830949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture.
    Shen M; Thayer SA
    Mol Pharmacol; 1999 Jan; 55(1):8-13. PubMed ID: 9882692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta-9-tetrahydrocannabinol (THC) history fails to affect THC's ability to induce place preferences in rats.
    Hempel BJ; Wakeford AG; Clasen MM; Friar MA; Riley AL
    Pharmacol Biochem Behav; 2016 May; 144():1-6. PubMed ID: 26905371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC).
    Scallet AC; Uemura E; Andrews A; Ali SF; McMillan DE; Paule MG; Brown RM; Slikker W
    Brain Res; 1987 Dec; 436(1):193-8. PubMed ID: 2825925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABAB receptor- and metabotropic glutamate receptor-dependent cooperative long-term potentiation of rat hippocampal GABAA synaptic transmission.
    Patenaude C; Chapman CA; Bertrand S; Congar P; Lacaille JC
    J Physiol; 2003 Nov; 553(Pt 1):155-67. PubMed ID: 12963794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the synthetic cannabinoid nabilone on spatial learning and hippocampal neurotransmission.
    Diana G; Malloni M; Pieri M
    Pharmacol Biochem Behav; 2003 Jun; 75(3):585-91. PubMed ID: 12895676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal development of GABA-mediated synaptic inhibition in rat hippocampus.
    Swann JW; Brady RJ; Martin DL
    Neuroscience; 1989; 28(3):551-61. PubMed ID: 2710330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular correlate of EPSP-spike potentiation in CA1 pyramidal neurons is controlled by GABAergic modulation.
    Staff NP; Spruston N
    Hippocampus; 2003; 13(7):801-5. PubMed ID: 14620875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation by dopamine of population spikes in area CA1 hippocampal neurons elicited by paired stimulus pulses.
    Gribkoff VK; Ashe JH
    Cell Mol Neurobiol; 1984 Jun; 4(2):177-83. PubMed ID: 6091884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.